Skip to main content
Clinical Trials/NCT02073734
NCT02073734
Completed
Phase 3

Effects of Preoperative Dexamethasone on Postoperative Quality of Recovery Following Vaginal Reconstructive Surgery: A Randomized Controlled Trial

TriHealth Inc.1 site in 1 country63 target enrollmentFebruary 2013

Overview

Phase
Phase 3
Intervention
Dexamethasone
Conditions
Pelvic Organ Prolapse
Sponsor
TriHealth Inc.
Enrollment
63
Locations
1
Primary Endpoint
The primary endpoint will be scores on the 40- item quality of recovery scoring system (QoR-40).
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

The investigators hypothesize that preoperative administration of 8 mg IV dexamethasone will benefit patients' perceived quality of recovery after surgery.

Detailed Description

This is a randomized controlled trial involving single administration of 8 mg Dexamethasone per IV preoperatively among women undergoing vaginal reconstructive surgery for pelvic organ prolapse.

Registry
clinicaltrials.gov
Start Date
February 2013
End Date
August 2014
Last Updated
10 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Women aged 18-81 years old who are scheduled to undergo a major vaginal reconstructive surgery, including hysterectomy with or without hysterectomy

Exclusion Criteria

  • Daily use of steroids or antiemetic agents such as Zofran, Reglan, Compazine and Phenargan within one month of surgery
  • Regional anesthesia for surgical procedure
  • Chronic pain requiring opioid treatment daily
  • History of allergy to the study medication
  • Severe renal and liver disease
  • Pregnancy
  • Non English speaking
  • Psychiatric disorder that will preclude completion of questionnaires
  • Minor surgery that does not involve overnight admission
  • Surgery that does not involve hysterectomy or vaginal intraperitoneal apical suspension

Arms & Interventions

Dexamethasone

Dexamethasone

Intervention: Dexamethasone

Placebo

Sterile normal saline solution

Intervention: Placebo

Outcomes

Primary Outcomes

The primary endpoint will be scores on the 40- item quality of recovery scoring system (QoR-40).

Time Frame: up to 20-24 hours after surgery

The QoR-40 is a validated standardized questionnaire that assesses the dimensions of physical functioning, mental health, cognitive functioning, symptoms, role and social functioning, general health perceptions, sleep and energy

Secondary Outcomes

  • To determine if dexamethasone has positive impact on other clinical recovery variables such as nausea, vomiting and pain.(20-24 hours after surgery)

Study Sites (1)

Loading locations...

Similar Trials